MINNEAPOLIS – Andrew Witty has been named CEO of UnitedHealth Group’s health information and technology firm, Optum, effective July 1. The company’s CEO, Larry Renfro, will take the lead of UnitedHealth Group’s enterprise growth efforts through Optum Ventures. Witty is the former CEO of GlaxoSmithKline and has served as a member of the UnitedHealth Group board of directors since 2017. Renfro will focus his work on UnitedHealth Group’s growth priorities. He will help accelerate the company’s innovation capacities and reach as managing partner of Optum Ventures, a series of domestic and international funds, including a new, $100 million Global Fund, dedicated to emerging and advanced technology, data analytics and health care services companies with transformative capabilities. Renfro joined UnitedHealth Group in 2009 as CEO for the Public and Seniors Market Group before becoming CEO of Optum in 2011 and also vice chairman in 2014. “I am both excited and grateful that Larry will partner with me at the enterprise level, dedicating his talents to strengthening our present day growth agenda and future capability development and strengthening of Optum through early-stage investing at Optum Ventures,” said David Wichmann, CEO of UnitedHealth Group, in a statement. “We are deeply fortunate in Andrew Witty to have the right person to extend Optum’s momentum and lead the business in its next phase of growth.” Following his new appointment, Witty will step down from the UnitedHealth Group board of directors, effective immediately.
You are here: / / Witty takes lead at Optum; Renfro heads up Optum Ventures